CT-P59
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for CT-P59, covering 2021-11-16 to 2022-07-20. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 2/3 Study to Evaluate the Efficacy and Safety of CT-P59 in Patients With Mild to Moderate SARS-CoV-2 Infection [Phase 2, Phase 3]